Clinical trial
Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related…
NCT00140803 · Manhattan Eye, Ear & Throat Hospital, Other · Completed
Key facts
| NCT number | NCT00140803 |
|---|---|
| Title | Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration |
| Official title | A Randomized, Single-Masked, Multi-Center, Phase 2 Evaluation Of The Effect Of PDT Using Visudyne In Combination With Intravitreal Injection Of Either 0 mg, 1mg or 4mg of Kenalog In Subfoveal Occult & Minimally Classic CNV Secondary To ARMD |
| Lead sponsor | Manhattan Eye, Ear & Throat Hospital, Other |
| Collaborators | Novartis Industry QLT Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | Visudyne, Kenalog |
| Enrollment | 106 |
| Start date | Oct 1, 2003 |
| Completion | Jan 1, 2007 |
| First posted | Sep 1, 2005 |
| Last update posted | Jul 12, 2007 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: